The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
The Food and Drug Administration released on Tuesday its long-awaited proposal to require food manufacturers to put some ...
The OIG report points to gaps in documentation and decision-making transparency, particularly in the case of Aduhelm, where FDA records indicated only 13 meetings with Biogen, but congressional ...
An OIG report zeroed in on what it said were three particularly problematic accelerated approvals: Biogen’s Aduhelm, ...
The AFIC process is intended to help FDA identify any potential safety concerns associated with animal food ingredients, provide information to the public, request input on animal food ingredients ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...